# Tyrosine Allergoid Paediatric and Adult Study

> **NCT05186025** · — · ACTIVE_NOT_RECRUITING · sponsor: **Allergy Therapeutics** · enrollment: 320 (actual)

## Conditions studied

- Allergic Rhinitis Due to Pollen
- Allergic Conjunctivitis
- Allergic Asthma

## Interventions

- **DRUG:** MATA trees or MATA grass

## Key facts

- **NCT ID:** NCT05186025
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-10
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186025, "Tyrosine Allergoid Paediatric and Adult Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05186025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*